Skip to main content
TipRanks
Go Ultimate75% OFF

Eli Samaha Insider Profile

11 Followers

Eli Samaha, Director at Stagwell, holds 9.17M shares in Theravance Biopharma (Ticker: TBPH), holds 8.19M shares in Stagwell (Ticker: STGW), holds 1.29M shares in Synovus (Ticker: SNV). Most recently, Eli Samaha Sold ― shares of Theravance Biopharma on Jul 08, 2026 for an estimated value of $119.39K.

Eli Samaha's Trading History

TBPH
Theravance Biopharma
Jul 08, 2026―Informative Sell119.39K$156.12M
STGW
Stagwell
Jul 02, 2026DirectorUninformative Buy19.99K$92.25M
SNV
Synovus
Jun 11, 2024―Informative Sell4.36M$64.73M
PFSW
PFSweb
Dec 30, 2022―Informative Sell15.66M$19.72M

You May Also Like

Eli Samaha insider profile FAQ

What is the percentage of profitable transactions made by Eli Samaha?
The percentage of profitable transactions made by Eli Samaha is 48%.
What is the average return per transaction made by Eli Samaha?
The average return per transaction made by Eli Samaha is 9.90%.
What stocks does Eli Samaha hold?
Eli Samaha holds: STGW, PFSW, SNV, TBPH stocks.
What was Eli Samaha’s latest transaction?
Eli Samaha’s latest transaction was an Informative Sell of $119.39K.
What was Eli Samaha's most profitable transaction?
Eli Samaha’s most profitable transaction was an Informative Buy of SNV stock on October 24, 2023. The return on the trade was 51.90%.
What is Eli Samaha's role in Stagwell?
Eli Samaha's role in Stagwell is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.